Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug? | Dementia and Cognitive Impairment | JAMA
This Medical News story examines the complexity of determining who to treat with lecanemab, the new Alzheimer disease drug.
Source: jamanetwork.com